🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 10 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/02/2018 17,73 18,17 17,04 17,66 +0,91% 6,37% 64.200
14/02/2018 17,19 17,62 17,19 17,50 +0,52% 2,50% 44.600
13/02/2018 17,13 17,75 16,97 17,41 +1,22% 4,55% 55.100
12/02/2018 17,63 17,63 16,53 17,20 -2,16% 6,24% 58.500
09/02/2018 17,29 17,76 16,47 17,58 +3,23% 7,46% 107.400
08/02/2018 17,74 17,86 17,02 17,03 -4,75% 4,74% 83.400
07/02/2018 17,83 18,53 17,62 17,88 -0,56% 5,10% 162.400
06/02/2018 20,06 20,20 17,90 17,98 -11,73% 11,44% 243.600
05/02/2018 21,43 21,63 20,34 20,37 -5,34% 6,02% 62.300
02/02/2018 22,54 22,90 21,39 21,52 -5,74% 6,70% 74.400
01/02/2018 22,76 23,75 22,73 22,83 -0,13% 4,48% 96.400
31/01/2018 22,17 23,10 21,65 22,86 +4,10% 6,56% 163.000
30/01/2018 21,96 22,40 21,37 21,96 +0,97% 4,69% 165.200
29/01/2018 19,99 22,50 19,95 21,75 +13,10% 12,76% 633.900
26/01/2018 19,55 20,00 19,12 19,23 -3,12% 4,50% 59.100
25/01/2018 19,24 20,30 19,24 19,85 +3,60% 5,51% 68.600
24/01/2018 19,55 19,62 18,66 19,16 -1,59% 4,91% 138.200
23/01/2018 18,98 19,78 18,83 19,47 +2,91% 4,98% 129.100
22/01/2018 19,06 19,41 18,80 18,92 -0,37% 3,20% 85.900
19/01/2018 19,09 19,62 18,65 18,99 -0,26% 5,11% 115.600
18/01/2018 19,51 19,63 18,96 19,04 -2,16% 3,43% 87.100
17/01/2018 19,58 20,02 19,19 19,46 +0,41% 4,24% 140.700
16/01/2018 19,90 20,32 19,02 19,38 -2,32% 6,53% 94.800
12/01/2018 20,19 20,27 19,73 19,84 -1,59% 2,67% 53.800
11/01/2018 20,66 20,66 20,08 20,16 -2,47% 2,81% 50.800
10/01/2018 19,77 20,79 19,47 20,67 +4,24% 6,68% 130.100
09/01/2018 19,66 20,03 19,34 19,83 +0,76% 3,50% 67.800
08/01/2018 20,54 21,02 19,57 19,68 -3,91% 7,04% 74.700
05/01/2018 21,10 21,17 20,19 20,48 -2,01% 4,64% 99.700
04/01/2018 21,32 21,50 20,83 20,90 -0,57% 3,14% 162.900